Solabia sharpens cosmetics focus with diagnostics divestment
Ingredient supplier Solabia is sharpening its focus on cosmetics, nutrition, and life sciences. Astorg, Solabia’s majority owner and pan-European private equity firm, has announced it is strategically repositioning the company’s portfolio. Solabia plans to divest its microbiology diagnostics division to enable it to concentrate on its core markets. Under the proposed transaction, the division will be acquired by Oxoid Remel Microbiology, an Astorg portfolio company acquired in August 2026.This Technical Paper is brought to you by Ashland.
David Gordon, co-founder and CEO at EvanHealy, talks to us about building a botanical skin care brand in an increasingly crowded market. He explains how EvanHealy’s approach to ethical sourcing centers on personal relationships with farmers and producers, trust, and working with people who have a deep understanding of the land. We also explore the impact of climate change on botanical skin care and why direct engagement with farms is becoming increasingly important to ensure an ethical relationship with botanical sourcing.
Settings
- Play Interval
- Slide Duration
- Thumbnail Bar Position
Latest headlines

Next-level “skinification” Oct 2026

Sustainable beauty solutionsOct 2026
Multimedia
David Gordon, co-founder and CEO at EvanHealy, talks to us about building a botanical skin care brand in an increasingly crowded market. He explains how EvanHealy’s approach to ethical sourcing centers on personal relationships with farmers and producers, trust, and working with people who have...































